Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Comprehensive Post-Acute Stroke Services
NCT02588664 · View on ClinicalTrials.gov ↗
Study Summary
The purpose of this pragmatic study is to investigate whether implementation of a comprehensive post-acute stroke service model that integrates Early Supported Discharge (ESD) and Transitional Care Management (TCM) for stroke survivors discharged home improves functional outcomes post-stroke, reduces caregiver stress, and reduces readmission rates.
Conditions Studied
Interventions
- OTHER COMPASS Intervention
Study Locations (20)
North Carolina
- CHS Stanly — Albemarle
- Mission Hospital — Asheville
- UNC Hospital — Chapel Hill
- CHS Carolinas Medical Center — Charlotte
- Novant Health Presbyterian Medical Center — Charlotte
- CHS Carolinas Medical Center-Mercy — Charlotte
- CHS University — Charlotte
- CHS Northeast — Concord
- Betsy Johnson Hospital — Dunn
- Morehead Memorial Hospital — Eden
- Hugh Chatham Memorial Hospital — Elkin
- Cape Fear Valley Medical Center — Fayetteville
- Angel Medical Center — Franklin
- Pardee Health — Hendersonville
- Frye Regional Medical Center — Hickory
- Novant Health Huntersville — Huntersville
- Onslow Memorial Hospital — Jacksonville
- Ashe Memorial Hospital — Jefferson
- Vidant Duplin Hospital — Kenansville
- CHS Kings Mountain — Kings Mountain
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,024 participants |
| Start Date | 2016-07-25 |
| Est. Completion | 2020-03-15 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02588664
The ClinicalTrials.gov registry entry for NCT02588664 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 6,024 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,061 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention — of which COMPASS Intervention is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT02588664 reports 20 study locations spanning 1 distinct geographic area — top geographies include North Carolina. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT02588664 about?
NCT02588664 is a clinical study titled "Comprehensive Post-Acute Stroke Services". The purpose of this pragmatic study is to investigate whether implementation of a comprehensive post-acute stroke service model that integrates Early Supported Discharge (ESD) and Transitional Care Management (TCM) for stroke survivors discharged home improves functional outcomes post-stroke, reduce...
What is the current status of trial NCT02588664?
This trial is currently completed. It is a NA study. The enrollment target is 6,024 participants. The study started on 2016-07-25. Estimated completion is 2020-03-15.
What conditions does trial NCT02588664 study?
This clinical trial studies the following conditions: Stroke, Transient Ischemic Attack. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT02588664?
The interventions under investigation include: COMPASS Intervention (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT02588664?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,061 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT02588664 being conducted?
This trial has 20 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.